白真菌素及其衍生物特异性识别HIV-1 LTR-III G-四链体

本申请涉及包含白真菌素和/或其衍生物的组合物，所述衍生物包括氯白真菌素、477-albo、492-albo、505-albo、506-1-albo、506-2-albo、519-albo和562-albo。本申请还涉及使用白真菌素和/或其衍生物治疗患有HIV的受试者的方法，所述衍生物包括氯白真菌素、477-albo、492-albo、505-albo、506-1-albo、506-2-albo、519-albo和562-albo。 The subject invention pertains to compositions comprising albofungin and/or deriva...

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageChinese
Published 15.03.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:本申请涉及包含白真菌素和/或其衍生物的组合物，所述衍生物包括氯白真菌素、477-albo、492-albo、505-albo、506-1-albo、506-2-albo、519-albo和562-albo。本申请还涉及使用白真菌素和/或其衍生物治疗患有HIV的受试者的方法，所述衍生物包括氯白真菌素、477-albo、492-albo、505-albo、506-1-albo、506-2-albo、519-albo和562-albo。 The subject invention pertains to compositions comprising albofungin and/or derivatives thereof, including, chloroalbofungin, 477-albo, 492-albo, 505-albo, 506-1-albo, 506-2-albo, 519-albo, and 562-albo. The subject invention further pertains to methods of treating a subject with HIV using albofungin and/or derivatives thereof, including, chloroalbofungin, 477-albo, 492-albo, 505-albo, 506-1-albo, 506-2-albo, 519-albo, and 562-albo.
Bibliography:Application Number: CN202210611366